Meli Hermine, Cissoko Yacouba, Konaté Issa, Soumaré Mariam, Fofana Assetou, Dembélé Jean Paul, Kaboré Mikaila, Cissé Mohamed Aly, Zaré Abdoulaye, Dao Sounkalo
Service des Maladies Infectieuses, Centre Hospitalier Universitaire du Point G Bamako, Bamako, Mali.
Faculté de Médecine et d´Odontostomatologie Bamako, Bamako, Mali.
Pan Afr Med J. 2020 Oct 8;37:141. doi: 10.11604/pamj.2020.37.141.22716. eCollection 2020.
Nosocomial infections are a real global public health problem. Pulmonary tuberculosis and HIV co-infection increases the incidence of nosocomial infections because of immunosuppression and iterative hospitalizations. We here report four cases of patients aged 28, 36, 42 and 52 years co-infected with HIV and tuberculosis (multifocal tuberculosis in 2 patients, miliary tuberculosis, bacteriologically confirmed tuberculosis), all with CD4 < 100 cells/mm. During the intensive-phase, patients received antitubercular drugs and antiretroviral therapy (ART). They had been admitted to the Department of Infectious Diseases at the G-Point University Hospital with productive cough and/or hyperthermia following hospital stay greater than 48 hours. Patients' history revealed that one patient had not been compliant with tuberculosis treatment because of adverse reactions classified as minor. There had been no clinical improvement in the three remaining patients despite their optimal compliance to different treatments. Cytobacteriological examination of sputum and/or testing of the feeding tubes, blood cultures and specific samples allowed to identify multidrug-resistant Klebsiella pneumoniae. The clinical course of these patients was favorable under specific antibiotic therapy. Nosocomial infections may be misinterpreted and associated with poor therapeutic response in patients receiving TB treatment. Cytobacteriological examination of the biological fluids should be systematic in patients co-infected with HIV and tuberculosis and hospitalized for at least 48 hours, in whom pulmonary signs and/or fever persist despite their good compliance to treatment.
医院感染是一个真正的全球公共卫生问题。肺结核与艾滋病病毒合并感染会因免疫抑制和反复住院而增加医院感染的发生率。我们在此报告4例年龄分别为28岁、36岁、42岁和52岁的艾滋病病毒与结核病合并感染患者(2例为多灶性肺结核,1例为粟粒性肺结核,均经细菌学确诊为结核病),所有患者的CD4细胞计数均<100个/mm³。在强化期,患者接受了抗结核药物和抗逆转录病毒治疗(ART)。他们因住院时间超过48小时后出现咳痰和/或高热而入住G点大学医院传染病科。患者病史显示,1例患者因轻微不良反应而未坚持结核病治疗。其余3例患者尽管对不同治疗有最佳依从性,但仍无临床改善。对痰液进行细胞细菌学检查和/或对饲管、血培养及特定样本进行检测,从而鉴定出耐多药肺炎克雷伯菌。在特定抗生素治疗下,这些患者的临床病程良好。医院感染可能会被误诊,并与接受结核病治疗患者的治疗反应不佳相关。对于艾滋病病毒与结核病合并感染且住院至少48小时、尽管治疗依从性良好但仍持续存在肺部症状和/或发热的患者,应对生物体液进行系统性的细胞细菌学检查。